Dr. Marta L. Feldmesser
Overview
Marta Feldmesser is an Infectious Disease provider in New York, New York. Dr. Feldmesser is rated as an Experienced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Listeriosis, and Pneumonia.
Her clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1421 3rd Avenue, 5th Floor, New York, NY 10028
122 East 76th Street, Suite 1C, New York, NY 10021
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Memorial Infectious Disease Group
Genovefa Papanicolaou is an Infectious Disease provider in New York, New York. Dr. Papanicolaou is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Cytomegalovirus Infection, Sepsis, Cytomegalic Inclusion Disease, and Pneumonia.
Montefiore At AECOM
Leadership: Dr. Nosanchuk is an internationally regarded leader in undergraduate medical education, serving most recently as the Senior Associate Dean for Medical Education at Einstein. From 2020-2023, he led a complete revision of the MD program curriculum that included launching new required longitudinal courses on service learning, scholarship, and health systems sciences, and transforming the training phases to a 17-month pre-clinical period followed by 12-months of clerkships and 18-months of individualized professional development. Dr. Nosanchuk has received various education and leadership awrds from Einstein and medical/scientific societies. Dr. Nosanchuk serves on various external education and society committees, including being a member of the Executive Board of the National Board of Medical Examiners. Dr. Nosanchuk is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Paracoccidioidomycosis, Cryptococcosis, Sporotrichosis, and Melioidosis.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- OsteomyelitisDr. Feldmesser isAdvanced. Learn about Osteomyelitis.
- Osteomyelitis in ChildrenDr. Feldmesser isAdvanced. Learn about Osteomyelitis in Children.
- Experienced
- AIDS Dementia ComplexDr. Feldmesser isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Feldmesser isExperienced. Learn about AIDS Dysmorphic Syndrome.
- Bacterial GastroenteritisDr. Feldmesser isExperienced. Learn about Bacterial Gastroenteritis.
- CellulitisDr. Feldmesser isExperienced. Learn about Cellulitis.
- EndocarditisDr. Feldmesser isExperienced. Learn about Endocarditis.
- HIV/AIDSDr. Feldmesser isExperienced. Learn about HIV/AIDS.